Master Data

Registry
Register court München HRB 262482
Registered
1/19/2021
Industry
Research and experimental development on biotechnologyOther research and experimental development on natural sciences and engineeringManufacture of basic pharmaceutical products
Purpose
Forschung auf dem Gebiet der Biotechnologie mit dem Zeil der Entwicklung und Lizenzierung neuroprotektiver Medikamente und Behandlungsmethoden.

History

No events found for this filter

Management

NameRole
Managing Director
Karl Bernd Zimmermann
since 1/19/2021
Managing Director

Beneficial Owners
Beta

Identified persons (28)

NameOwnership
55.10%
Y***** F******* D*****
19.95%
A******** C*********
9.50%

Unresolved chains (3)

NameOwnership
Neurevo GmbHSelf-held cycle
0.97%

Shareholders
Beta

7 shareholders

GmbH structure

5 of 7 shown

Name
Location
Amount
Share
Beltane Investments UG (haftungsbeschränkt)
Germany
€45,240
55.10%
Y***** F******* D*****
€16,380
19.95%
A******** C*********
€7,800
9.50%
B**** Z*********
€7,000
8.53%
SYSTASY Bioscience GmbH
Germany
€4,105
5.00%

Holdings
Beta

NameOwnership
0.97%

News & Media Coverage

Insolvency Notices

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Shareholder List
Current Print (Aktueller Abdruck)
Chronological Print (Chronologischer Abdruck)

Organizations at this Address

32 nearby organizations

List of companies and organizations located at or near this business address. Data includes company names, addresses, registration details, and industry classifications.
The information on this page is sourced from public sources, official registries, or provided by third-party providers. Fusionbase does not guarantee the accuracy, completeness, or timeliness of the data. If you have any questions or suggestions, feel free to contact us via the contact form.